02/10/2026
Thank you to Nancy Chan MD from NYU Langone Healthfor a great discussion at Englewood Hospital and Medical Center on advances in ER-positive breast cancer, including efforts to expand the role of neoadjuvant therapy for more women with ER+/HER2− disease. The I-SPY trial Quantum Leap Health Consortium is a great trial to expand the role of NAT for pts. Glad to see such meaningful progress being made, with many novel agents on the horizon